nova

Where the Big Money Is Betting Big

This is a good written paper.

Big Pharma became big utility companies, i.e., very little innovation and lots of bureaucracy but they have lots of cash. Furthermore, many biotech have good and promising drugs they developed but, at the same time, they have neither manufacturing nor marketing resources and expertise to move successfully forward and realize the full commercial potential of their products. Consequently, biotech with real breakthrough products are always ready to explode.

It is obvious that the present US reckless and irresponsible financial and economic policies gravely undermined US$ as a reserve currency. Moving forward, the world financial system is in a "no-man" territory. Euro and other currencies are not about to gain strong acceptance due to various problems especially with Asian countries. So, after all, we are back to gold and strategic commodities.

Dennis Gartman on Gold, Oil, Government and the Economy

"Before devoting himself full-time to The Gartman Letter, Dennis analyzed cotton supply and demand in the U.S. textile industry as an economist for Cotton, Inc."

He should stay with cotton...